Mateusz Maniewski
Overview
Explore the profile of Mateusz Maniewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skrok M, Tamborski S, Hepburn M, Fang Q, Maniewski M, Zdrenka M, et al.
Biomed Opt Express
. 2024 Dec;
15(12):6816-6833.
PMID: 39679405
Prostate cancer is a global health issue that requires new diagnostic methods to provide accurate and precise visualization of prostate tissue on the micro-scale. Such methods have the potential to...
2.
Borowczak J, Gasiorek-Kwiatkowska A, Szczerbowski K, Maniewski M, Zdrenka M, Szadurska-Noga M, et al.
Diseases
. 2024 Jul;
12(7).
PMID: 39057113
Background: SARS-CoV-2 can damage human placentas, leading to pregnancy complications, such as preeclampsia and premature birth. This study investigates the histopathological changes found in COVID-19-affected placentas. Materials And Methods: This...
3.
Andreou M, Jakalski M, Duzowska K, Filipowicz N, Kostecka A, Davies H, et al.
Int J Cancer
. 2024 Jun;
155(9):1616-1628.
PMID: 38850108
Despite advances in early detection and treatment strategies, breast cancer recurrence and mortality remain a significant health issue. Recent insights suggest the prognostic potential of microscopically healthy mammary gland, in...
4.
Kowalewski A, Borowczak J, Maniewski M, Gostomczyk K, Grzanka D, Szylberg L
Biomed Pharmacother
. 2024 May;
175:116805.
PMID: 38781868
Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of renal cancer, accounting for approximately 80% of all renal cell cancers. Due to its exceptional inter- and intratumor...
5.
Borowczak J, Zdrenka M, Socha W, Gostomczyk K, Szczerbowski K, Maniewski M, et al.
Clin Transl Oncol
. 2024 May;
26(10):2549-2558.
PMID: 38769215
Introduction: Due to its lack of conventional surface receptors, triple-negative breast cancer (TNBC) is inherently resistant to most targeted therapies. MAL2 overexpression prompts endocytosis, conferring resistance to novel therapeutics. This...
6.
Gostomczyk K, Borowczak J, Siekielska-Domanowska M, Szczerbowski K, Maniewski M, Dubiel M, et al.
Arch Immunol Ther Exp (Warsz)
. 2024 Feb;
72(1).
PMID: 38299561
The widespread occurrence of SARS-CoV-2 infections and the diverse range of symptoms have placed significant strain on healthcare systems worldwide. Pregnancy has also been affected by COVID-19, with an increased...
7.
Zdrenka M, Kowalewski A, Ahmadi N, Sadiqi R, Chmura L, Borowczak J, et al.
Biomol Biomed
. 2023 Oct;
24(1):14-29.
PMID: 37877810
Anti-programmed cell death ligand 1 (anti-PD-L1) immunotherapy is an increasingly crucial in cancer treatment. To date, the Federal Drug Administration (FDA) has approved four PD-L1 immunohistochemistry (IHC) staining protocols, commercially...
8.
Gostomczyk K, Marsool M, Tayyab H, Pandey A, Borowczak J, Macome F, et al.
Hum Cell
. 2023 Oct;
37(1):101-120.
PMID: 37874534
Circulating tumor cells (CTCs) are cancer cells that detach from the primary tumor, enter the bloodstream or body fluids, and spread to other body parts, leading to metastasis. Their presence...
9.
Kowalewski A, Jaworski D, Borowczak J, Maniewski M, Szczerbowski K, Antosik P, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499030
Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC). Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We explored the relationship...
10.
Borowczak J, Szczerbowski K, Maniewski M, Zdrenka M, Slupski P, Andrusewicz H, et al.
Clin Transl Oncol
. 2022 Nov;
25(3):830-840.
PMID: 36374405
Purpose: The mutation of p53 is considered a pivotal step in bladder cancer pathogenesis. Recently, distinct interactions between p53 and CDK9, a transcription regulator, have been described. In this work,...